Gene Expression Profiling in the Midbrain of Striatal 6-Hydroxydopamine-Injected Mice

Synapse

Volumn 51, Issue 4, 2004, Pages 279-286

  Iwata, Shin Ichi ^a   Nomoto, Masahiro ^b   Morioka, Hirofumi ^c   Miyata, Atsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

6 hydroxydopamine; ATAC PCR; Cyclin D1; Gene expression profiling; Parkinson's disease

Indexed keywords

CASPASE 8; CYCLIN D1; MESSENGER RNA; NERVE GROWTH FACTOR; OXIDOPAMINE; PERIPHERAL MYELIN PROTEIN 22; PROTEIN KINASE B; PROTEIN P53; SERUM AND GLUCOCORTICOID REGULATED KINASE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENE ACTIVATION; GENE EXPRESSION; MALE; MESENCEPHALON; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; UNINDEXED SEQUENCE;

ANIMALS; BRAIN CHEMISTRY; CELL SURVIVAL; GENE EXPRESSION PROFILING; MALE; MESENCEPHALON; MICE; OXIDOPAMINE; PARKINSONIAN DISORDERS;

EID: 0942276227     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10307     Document Type: Article

References (46)

1. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T. 2000. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14:704-718.
2. Berger K, Przedborski S, Cadet JL. 1991. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res Bull 26:301-307.
3. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172.
4. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952-965.
5. Cadet JL, Zhu SM. 1992. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal makers in the rat. Brain Res 595:316-326.
6. Cadet JL, Last R, Kostic V, Przedborski S, Jackson-Lewis V. 1991. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Brain Res Bull 26:707-713.
7. Coccia EM, Cicala C, Charlesworth A, Ciccarelli C, Rossi GB, Philipson L, Sorrentino V. 1992. Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. Mol Cell Biol 12:3514-3521.
8. Crowder RJ, Freeman RS. 1998. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 18:2933-2943.
9. Cutillas B, Espejo M, Gil J, Ferrer I, Ambrosio S. 1999. Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration. Neuroreport 10:2605-2608.
10. Datta SR, Brunet A, Greenberg ME. 1999. Cellular survival: a play in three Akts. Genes Dev 13:2905-2927.
11. Davis PK, Dudek SM, Johnson GV. 1997. Select alterations in protein kinases and phosphatases during apoptosis of differentiated PC12 cells. J Neurochem 68:2338-2347.
12. Downward J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262-267.
13. Espino A, Cutillas B, Tortosa A, Ferrer L, Bartrons R, Ambrosio S. 1995. Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats. Brain Res 695:151-157.
14. Fillon S, Warntges S, Matskevitch J, Moschen I, Setiawan I, Gamper N, Feng YX, Stegen C, Friedrich B, Waldegger S, Broer S, Wagner CA, Huber SM, Klingel K, Vereninov A, Lang F. 2001. Serum- and glucocorticoid-dependent kinase, cell volume, and the regulation of epithelial transport. Comp Biochem Physiol A Mol Integr Physiol 130:367-376.
15. Freeman RS, Estus S, Johnson EM Jr. 1994. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355.
16. Furukawa-Hibi Y, Yoshida-Araki K, Ohta T, Ikeda K, Motoyama N. 2002. FOXO forkhead transcription factors induce G(2)-M checkpoint in response to oxidative stress. J Biol Chem 277:26729-26732.
17. Grünblatt E, Mandel S, Maor G, Youdim MB. 2001. Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine. J Neurochem 78:1-12.
18. Ichitani Y, Okamura H, Matsumoto Y, Nagatsu I, Ibata Y. 1991. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res 549:350-353.
19. Ichitani Y, Okamura H, Nakahara D, Nagatsu I, Ibata Y. 1994. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra. Exp Neurol 130:269-278.
20. Imaizumi K, Tsuda M, Wanaka A, Tohyama M, Takagi T. 1994. Differential expression of sgk mRNA, a member of the Ser/Thr protein kinase gene family, in rat brain after CNS injury. Brain Res Mol Brain Res 26:189-196.
21. Iwata SI, Nomoto M, Fukuda T. 2001. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine. Synapse 39:16-22.
22. Jenner P, Schapira AH, Marsden CD. 1992. New insights into the cause of Parkinson's disease. Neurology 42:2241-2250.
23. Katchanov J, Harms C, Gertz K, Hauck L, Waeber C, Hirt L, Priller J, von Harsdorf R, Bruck W, Hortnagl H, Dirnagl U, Bhide PG, Endres M. 2001. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J Neurosci 21:5045-5053.
24. Kato K. 1997. Adaptor-tagged competitive PCR: a novel method for measuring relative gene expression. Nucleic Acids Res 25:4694-4696.
25. Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, Huang TT, Bos JL, Medema RH, Burgering BM. 2002. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:316-321.
26. Lee CS, Sauer H, Bjöklund A. 1996. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience 72:641-653.
27. Lindsay RM, Altar CA, Cedarbaum JM, Hyman C, Wiegand SJ. 1993. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Exp Neurol 124:103-118.
28. Liu DX, Greene LA. 2001. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res 305:217-228.
29. Mandel S, Grünblatt E, Youdim M. 2000. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease. J Neural Transm Suppl 60:117-124.
30. Mandel S, Grünblatt E, Maor G, Youdim M. 2002. Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray. Neurochem Res 27:1231-1243.
31. Motokura T, Keyomarsi K, Kronenberg HM, Arnold A. 1992. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J Biol Chem 267:20412-20415.
32. Padmanabhan J, Park DS, Greene LA, Shelanski ML. 1999. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J Neurosci 19:8747-8756.
33. Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM. 1995. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631-647.
34. Sauer H, Oertel WH. 1994. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415.
35. Sauer H, Rosenblad C, Björklund A. 1995. Glial cell line-derived neurotrophic factor but not transforming growth factor β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA 92:8935-8939.
36. 3H-tryptophan in various regions of the rat brain. Eur J Pharmacol 17:75-80.
37. Segura-Aguilar J, Baez S, Widersten M, Welch CJ, Mannervik B. 1997. Human class Mu glutathione transferases, in particular isoenzyme M2-2, catalyze detoxication of the dopamine metabolite aminochrome. J Biol Chem 272:5727-5731.
38. Sherman TG, Moody CA. 1995. Alterations in tyrosine hydroxylase expression following partial lesions of the nigrostriatal bundle. Brain Res Mol Brain Res 29:285-296.
39. Sherr CJ. 1995. D-type cyclins. Trends Biochem Sci 20:187-190.
40. Shintani M, Okazaki A, Masuda T, Kawada M, Ishizuka M, Doki Y, Weinstein IB, Imoto M. 2002. Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression. Anticancer Res 22:639-647.
41. Shirvan A, Ziv I, Zilkha-Falb R, Machlyn T, Barzilai A, Melamed E. 1998. Expression of cell cycle-related genes during neuronal apoptosis: is there a distinct pattern? Neurochem Res 23:767-777.
42. Timsit S, Rivera S, Ouaghi P, Guischard F, Tremblay E, Ben-Ari Y, Khrestchatisky M. 1999. Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death? Eur J Neurosci 11:263-278.
43. Tran H, Brunet A, Grenier JM, Datta SR, Fornace AJ Jr, DiStefano PS, Chiang LW, Greenberg ME. 2002. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 296:530-534.
44. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. 1993. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 13:2031-2040.
45. Yuan J, Yankner BA. 2000. Apoptosis in the nervous system. Nature 407:802-809.
46. Zheng WH, Kar S, Quirion R. 2002. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem 80:1049-1061.